Back

Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation: Final Phase II results of the GLORIA-AF Registry Program

20 March 2018 (11:38 - 11:51)
Organised by:
Congress Presentation Part of: Late-breaking science - Registries Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Safety and acute effectiveness of a new ultra-high density mapping system for ablation of arrhythmias.
Professor G. Hindricks (Berlin, DE)
Presentation thumbnail
Ablation of paroxysmal and persistent atrial fibrillation using a flexible tip ablation catheter: Outcomes from the ABLATOR registry
Doctor Y. Yao (Beijing, CN)
Slides Video
Presentation thumbnail
Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21,141 procedures in the Helios atrial fibrillation ablation registry (SAFER)
Doctor L. Ueberham (Leipzig, DE)
Slides Video
Presentation thumbnail
Evaluating real-life clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology
Professor L. Boersma (Nieuwegein, NL)
Slides Video
Presentation thumbnail
Optimization of ICD programming in practice- diffusion rate of clinical trial results and consensus recommendations measured in a large cohort of implantable cardioverter defibrillator patients
Doctor N. Varma (Cleveland, US)

Access the full session

Session thumbnail
Late-breaking science - Registries

The Event

Event poster

EHRA 2018

20 March 2018 11:38 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources